How to work with a preclinical contract research organization

When outsourcing medical device laboratory testing, knowing what the regulatory and business requirements are up front is critical to the success of your testing program. Amy A. Schade, Felice Randi LaMadeleine and J. Heléne Andersson, Toxikon Requests such as unusual application of technical or regulatory guidelines, shortened timelines, nonstandard study designs and custom reports are

Nelson Labs parent Sterigenics buys Toxikon’s European lab business

Sterigentics International is seeking to turn its Nelson Labs business into a global extractables and leachables lab testing platform through its acquisition of Toxikon’s European division. The purchase of Toxikon Europe, announced yesterday, represents a capabilities expansion when it comes to serving the pharmaceutical and medical device industries. Sterigenics’s Nelson Labs business will now offer Toxikon

5 DeviceTalks Boston exhibitors you should know

DeviceTalks Boston is an annual event that allows some of the best minds in medtech to exchange ideas, insights and technologies. The event is hosted by Medical Design & Outsourcing’s sister site MassDevice. Those who attend the event can expect to network with other medtech enthusiasts, attend in-depth interviews with leaders in the industry and

Pages: 1 2 3 4 5 6

Toxikon showcasing preclinical testing services at DeviceTalks Boston

Toxikon is a preclinical Contract Research Organization (CRO) located in an FDA registered and ISO 17025 accredited laboratory facility in Bedford, Mass., and a second European lab operation in Leuven, Belgium. The company contracts and partners with biotech, pharmaceutical and medical device industries to deliver product development services from concept to final product. Its professional